Skip to main content
Signal8

Leaman John Harold

SEC insider (Form 3/4/5 filer). CIK 0001586657. Director at Traws Pharma, Inc. (TRAW). 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 9, 2026. Located in NEWTOWN, PA.

Companies Leaman John Harold has filed insider reports for

  • Traws Pharma, Inc. (TRAW): Director
Leaman John Harold profile photo

Leaman John Harold

CIK: 0001586657

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Traws Pharma, Inc. logo
TRAW

Traws Pharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Traws Pharma, Inc. logo
    TRAW

    Traws Pharma, Inc.

    Jul 9, 2026
    Award

    Stock Option (right to buy)

    Direct
    14.2K shares-
  • Traws Pharma, Inc. logo
    TRAW

    Traws Pharma, Inc.

    Mar 8, 2026
    Award

    Stock Option (right to buy)

    Direct
    33.4K shares-
  • Traws Pharma, Inc. logo
    TRAW

    Traws Pharma, Inc.

    Dec 12, 2025
    Award
    Direct
    4.1K shares-
  • Traws Pharma, Inc. logo
    TRAW

    Traws Pharma, Inc.

    Nov 21, 2025
    Award

    Stock Option (right to purchase)

    Direct
    12.8K shares-
  • Traws Pharma, Inc. logo
    TRAW

    Traws Pharma, Inc.

    Oct 1, 2025
    Award

    Stock Option (right to purchase)

    Direct
    15.6K shares-

1-5 of 5